These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 4567377)

  • 21. Increased susceptibility of TNF-alpha lymphotoxin-alpha double knockout mice to systemic candidiasis through impaired recruitment of neutrophils and phagocytosis of Candida albicans.
    Netea MG; van Tits LJ; Curfs JH; Amiot F; Meis JF; van der Meer JW; Kullberg BJ
    J Immunol; 1999 Aug; 163(3):1498-505. PubMed ID: 10415052
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protective immune responses against systemic candidiasis mediated by phage-displayed specific epitope of Candida albicans heat shock protein 90 in C57BL/6J mice.
    Wang G; Sun M; Fang J; Yang Q; Tong H; Wang L
    Vaccine; 2006 Aug; 24(35-36):6065-73. PubMed ID: 16842891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of rubomycin and carminomycin on the delayed hypersensitivity reaction in mice immunized with ram erythrocytes].
    Vatin AE
    Antibiotiki; 1981 Oct; 26(10):750-3. PubMed ID: 6975599
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Precipitins to Candida albicans in chronic mucocutaneous candidiasis studied by crossed immunoelectrophoresis with intermediate gel. Correlation with clinical and immunological findings.
    Axelsen NH; Kirkpatrick CH; Buckley RH
    Clin Exp Immunol; 1974 Jul; 17(3):385-94. PubMed ID: 4619788
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune response and leukemia virus infection in the mouse.
    Collavo D; Biasi G; Colombatti A; Chieco-Bianchi L
    Boll Ist Sieroter Milan; 1974; 53(1):suppl:296. PubMed ID: 4604562
    [No Abstract]   [Full Text] [Related]  

  • 26. [The colonization of the intestinal tract by Candida albicans and the occurrence of anti-Candida-antibodies in humans (author's transl)].
    Böhme H; Ziegler H
    Dermatol Monatsschr; 1978 Sep; 164(9):652-5. PubMed ID: 361454
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunity to Candida albicans: Th1, Th2 cells and beyond.
    Romani L
    Curr Opin Microbiol; 1999 Aug; 2(4):363-7. PubMed ID: 10458979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The C-terminal antibody binding domain of Candida albicans mp58 represents a protective epitope during candidiasis.
    Viudes A; Lazzell A; Perea S; Kirkpatrick WR; Peman J; Patterson TF; Martinez JP; López-Ribot JL
    FEMS Microbiol Lett; 2004 Mar; 232(2):133-8. PubMed ID: 15033231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Immunologic reaction induced by Candida albicans (1. continuation)].
    Seeliger HP; Tomsikova A; Török I
    Mykosen; 1975 Mar; 18(3):119-34 contd. PubMed ID: 1094282
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunological and pathological observations with Candida albicans-infected animals.
    Kuttin ES; Müller J; Douchet C; Vogt A
    Sabouraudia; 1983 Sep; 21(3):185-94. PubMed ID: 6356407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic analysis of innate immunity in resistance to Candida albicans.
    Tuite A; Mullick A; Gros P
    Genes Immun; 2004 Nov; 5(7):576-87. PubMed ID: 15372070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experimental vaccination with Candida albicans ribosomes in cyclophosphamide-treated animals.
    Segal E; Sandovsky-Losica H
    Sabouraudia; 1981 Dec; 19(4):267-73. PubMed ID: 7034238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single-organism model of host defense against infection: a novel immunotoxicologic approach to evaluate immunomodulatory drugs.
    Herzyk DJ; Ruggieri EV; Cunningham L; Polsky R; Herold C; Klinkner AM; Badger A; Kerns WD; Bugelski PJ
    Toxicol Pathol; 1997; 25(4):351-62. PubMed ID: 9280118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Murine candidiasis: cell-mediated immune responses correlate directly with susceptibility and resistance to infection.
    Ashman RB
    Immunol Cell Biol; 1990 Feb; 68 ( Pt 1)():15-20. PubMed ID: 2180815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of antilymphocytic antibody on the humoral immune response in different strains of mice. II. The response to sheep erythrocytes.
    Ghaffar A; James K
    Immunology; 1973 Mar; 24(3):455-65. PubMed ID: 4574575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The clearance of colloidal carbon from the blood of Candida albicans infected mice.
    Sipka S; Balogh E
    Mykosen; 1983 Dec; 26(12):605-7. PubMed ID: 6363918
    [No Abstract]   [Full Text] [Related]  

  • 37. Candida albicans mannan extract-protein conjugates induce a protective immune response against experimental candidiasis.
    Han Y; Ulrich MA; Cutler JE
    J Infect Dis; 1999 Jun; 179(6):1477-84. PubMed ID: 10228070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunodeficient CBA/N mice respond effectively to Candida albicans.
    Carrow EW; Hector RF; Domer JE
    Clin Immunol Immunopathol; 1984 Dec; 33(3):371-80. PubMed ID: 6388927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Longitudinal cell mediated immune responses and cross reactivity of lymphocytes from rabbits infected with Candida albicans.
    Shi YE
    J Tongji Med Univ; 1986; 6(2):89-92. PubMed ID: 3528515
    [No Abstract]   [Full Text] [Related]  

  • 40. Suppressive action of Candida albicans on the immune response in mice.
    Vardinon N; Segal E
    Exp Cell Biol; 1979; 47(4):275-80. PubMed ID: 381071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.